Diabetes Mellitus is one of the major killers of the modern world. According to WHO the number of people living with diabetes has nearly quadrupled since 1980 to 422 million adults, most of who live in developing countries including India. Approximately 65 million Indians are living with diabetes currently, compared to 50.8 million in 2010.
Diabetes has been discussed at length in the ancient texts of Ayurveda and is referred to as Madhumeha, a palliative disease that cannot be completely cured, but can be controlled by food and medicine.
QNET has partnered with an Ayurveda research and development lab in the state of Uttar Pradesh to develop Nutriplus Nature Diabahealth, exclusively for its customers in India.
The product’s composition includes a proprietary blend of ten ingredients. The key ingredient, Kino (Malabar kino), contains a bioactive compound called ‘Epicatechin’ which has been proven to be a natural insulin mimetic (NAISUMI). In addition, ingredients such as Karela (Bitter gourd) and Jambul (Indian blackberry) have been clinically proven to aid the absorption of sugar from blood to cells, leading to better management of blood sugar levels.
DiabaHealth is formulated using Bioplantex Technology which involves a one-step extraction process of bioactive compounds to ensure minimum deterioration of the extracts, and results in higher levels of bioactivity and yield of the key molecules.
DiabaHealth is manufactured in India in a WHO GMP, ISO Certified and HACCP certified manufacturing facility.